Advertisement

The Effect of Acetylcholinesterase Inhibitors on Acetylcholinesterase in Senile Plaque, Normal Human or Rat Brain, Human Erythrocyte or Rat Skeletal Muscle

  • S. Nakamura
  • M. Yukawa
  • Y. Mimori
Part of the Advances in Behavioral Biology book series (ABBI, volume 44)

Abstract

The cholinergic system is affected in the brain of patients with Alzheimer’s disease, depleting choline acetyltransferase and acetylcholinesterase (AChE). Histochemical studies on AChE distribution in the cerebral cortex have revealed a difference between control subjects and Alzheimer patients.’ We have also demonstrated biochemically the difference in the subcellular distribution of AChE between control subjects and Alzheimer patients.2 The highest specific activity of AChE was detected in the fraction enriched with senile plaque.’

Keywords

Alzheimer Patient AChE Activity Alzheimer Brain Senile Plaque Supernatant Solution 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    M.M. Mesulam and M.A. Moran, Cholinesterases within neurofibrillary tangles related to age and Alzheimer’s disease, Ann. Neurol. 22: 223 (1987).Google Scholar
  2. 2.
    S. Nakamura, S. Kawashima, S. Nakano, T. Tsuji, and W. Araki, Subcellular distribution of acetylcholinesterase in Alzheimer’s disease; abnormal localization and solubilization, J. Neural Transm. 30[Suppl1:13(1990).Google Scholar
  3. 3.
    S. Nakamura, K. Koshimura, S. Tanak, Y. Mimori, and N. Kitaguchi, Qualitative changes of neurotransmitters in Alzheimer’s disease, in: “Frontiers of Alzheimer Research, T. Ishii, D. Allsop, D.J.Selkoe, ed., Elsevier, Amsterdam (1991).Google Scholar
  4. 4.
    S.G. Younkin, C. Rosenstein, P.L. Collins, and T.L. Rosenberry, Cellular localization of the molecular forms of acetylcholinesterase in rat diaphragm, J. Biol. Chem. 257: 13630 (1982).Google Scholar
  5. 5.
    J.M. Candy, J. Klinowski, R.H. Perry, A. Fairbrain, A.E. Oakley, T.A. Carpenter, J.R. Atack, G. Blessed, and J.A. Edwardson, Aluminosilicates and senile plaque formation in Alzheimer’s disease, Lancet, 1; 354 (1986).Google Scholar
  6. 6.
    S. Nakano, T. Kato, S. Nakamura, and M. Kameyama, Acetylcholinesterase activity in cerebrospinal fluid of patients with Alzheimer’s disease and senile dementia, J. Neurol. Sci. 75: 213 (1986).Google Scholar
  7. 7.
    O.H. Lowry, N.J. Rosenbrough, A.L. Farr, and R.J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193: 265 (1951).Google Scholar
  8. 8.
    R.G. Martin and B.N. Ames, A method for determining the sedimentation behavior of enzymes - Application to protein mixtures, J. Biol. Chem. 236: 1372 (1961).Google Scholar
  9. 9.
    S.G. Younkin, B. Goodridge, J. Katz, G. Lockett, D. Nafziger, M.F. Usik, and L.H. Younkin, Molecular forms of acetylcholinesterase in Alzheimer’s disease, Fed. Proc. 45: 2982 (1986).Google Scholar
  10. 10.
    M.M. Mesulam, C. Guela, M.A. Moran, Anatomy of cholinesterase inhibition in Alzheimer’s disease; effect of physostigmine and tetraaminoacridine on plaques and tangles, Ann. Neurol. 22: 683 (1987).Google Scholar
  11. 11.
    D.S. Navatnam, J.D. Priddle, B. McDonald, M.M. Esiri, J.R. Robinson, A.D. Smith, Anomalous molecular form of acetylcholinesterase in cerebrospinal fluid in histochemically diagnosed Alzheimer’s diseAcp, Lancet 337: 447 (1991).Google Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • S. Nakamura
    • 1
  • M. Yukawa
    • 1
  • Y. Mimori
    • 1
  1. 1.Third Dept of Internal MedicineHiroshima University School of MedicineHiroshima 734Japan

Personalised recommendations